2022
DOI: 10.1021/acs.bioconjchem.2c00231
|View full text |Cite
|
Sign up to set email alerts
|

Development of [18F]AmBF3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [18F]AmBF3-PEG7-Tyr3-Octreotide in an AR42J Pancreatic Carcinoma Model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(19 citation statements)
references
References 30 publications
1
18
0
Order By: Relevance
“…95 Two Tyr 3 octreotide (TOC)based radiotracers were synthesized using IEDDA between a [ 18 F]F-Tz derivative with a 19 F− 18 F-exchange-generated AmBF 3 moiety and a TCO-modified octreotide precursor with PEG linkers. 96 In this study, the authors demonstrated that [ 18 F]AmBF 3 -Tz is a promising radiolabeling agent for biomolecules.…”
mentioning
confidence: 79%
See 1 more Smart Citation
“…95 Two Tyr 3 octreotide (TOC)based radiotracers were synthesized using IEDDA between a [ 18 F]F-Tz derivative with a 19 F− 18 F-exchange-generated AmBF 3 moiety and a TCO-modified octreotide precursor with PEG linkers. 96 In this study, the authors demonstrated that [ 18 F]AmBF 3 -Tz is a promising radiolabeling agent for biomolecules.…”
mentioning
confidence: 79%
“…Based on the use of TTCO ligation, a PET probe [ 18 F]­TTCO-Cys-exendin-4, prepared in a high specific activity, demonstrated the higher specific binding to the GLP-1 receptor (GLP-1R) and lower background-to-tumor ratio for imaging transplanted islets in comparison with the radiometal-labeled exendin-4 . Two Tyr octreotide (TOC)-based radiotracers were synthesized using IEDDA between a [ 18 F]­F-Tz derivative with a 19 F– 18 F-exchange-generated AmBF 3 moiety and a TCO-modified octreotide precursor with PEG linkers . In this study, the authors demonstrated that [ 18 F]­AmBF 3 -Tz is a promising radiolabeling agent for biomolecules.…”
Section: Radiolabeling Of Targeted Ligand Moleculesmentioning
confidence: 99%
“…Since then, The AmBF 3 -chemistry has been utilised for direct IEX radiolabelling of various other peptides. 38,39 The last example regards the work of Otaru et al 40 who developed a novel prosthetic group [ 18 F]AmBF 3 tetrazine ([ 18 F]-AmBF 3 -Tz) suitable for the chemoselective radiolabelling of trans-cyclooctene (TCO)-modified biomolecules. As a model system, they radiolabelled two Tyr3 -octreotides (TOCs), analogues of somatostatin 41 , in a proof-of-concept study evaluating the influence of the novel prosthetic group on the pharmacokinetics of the wellknown peptide analogues in vivo.…”
Section: Direct Labellingmentioning
confidence: 99%
“…Based on our investigation with AmBF 3 -TOC derivatives radiolabelled with uorine-18 using the tetrazine ligation, we concluded that the oxidized pyridazine is extremely stable, resisting reduction to DHPs even in vivo. 19 Recently, Litau et al reported several side-products during radiometal labelling of peptides with IEDDA-based tetrazine ligation. 20 In their study, DOTA-GA-Tz and NODA-GA-Tz were radiolabelled with gallium-68 and copper-64 prior to the IEDDAmediated conjugation to the TCO-peptide, which resulted in formation of unknown side products.…”
Section: Introductionmentioning
confidence: 99%